Breast Cancer | Oncology Today with Dr Neil Love: Adjuvant Therapy for ER-Positive Breast Cancer

published 8 months ago by Dr Neil Love

Featuring a discussion on recent data with CDK4/6 inhibitors in adjuvant therapy for ER-positive breast cancer with Prof Stephen Johnston, including the following topics: Management of Localized ER-Positive, HER2-Negative Early Breast Cancer: Recent Advances in Adjuvant Systemic Endocrine-Based Therapies — Stephen Johnston, MA, PhD (0:00) Case: A postmenopausal woman in her mid-50s with high-risk ER-positive, HER2-negative breast cancer who receives abemaciclib in addition to standard adjuvant hormonal therapy on the monarchE trial (24:37) Case: A woman in her mid-40s with recurrent ER-positive, HER2-negative breast cancer and oligometastatic disease to the bones (29:14) Case: A premenopausal woman in her mid-40s with ER-positive, HER2-negative breast cancer and a 21-gene assay Recurrence Score® of 19 (33:07) CME information and select publications

more episodes from Research To Practice | Oncology Videos